Literature DB >> 23661991

Simultaneous determination of 10 components in traditional Chinese medicine Dachaihu Granule by reversed-phase-high-performance liquid chromatographic-diode array detector.

Yingfei Hu1, Tulin Lu, Chunqin Mao, Hao Wu, Xing Zhang, Jv Wang, Juanjuan Gu.   

Abstract

BACKGROUND: Dachaihu Granule, commonly used for treating pan class="Disease">cholecystitis, is derived from a famous traditional Chinese formula named Dachaihu Decoction. No analytical method has been reported for simultaneous determination of 10 bioactive compounds for quality control in Dachaihu Granule so far.
OBJECTIVE: To develop a high-performance liquid chromatographic (HPLC) method with diode array detector (DAD) for simultaneous determination of 10 bioactive compounds (paeoniflorin, aloe-emodin, rhein, emodin, chrysophanol, physcion, naringin, hesperidin, neohesperidin, and baicalin) in traditional Chinese medicine Dachaihu Granule.
MATERIALS AND METHODS: The samples were separated on a Kromasil C18 (250 × 4.6 mm,i.d. with 5.0 μm particle size)column with multi-wavelength detection method by a gradient elution using acetonitrile (A) and 0.2% acetic acid (B) as the mobile phase. The column temperature was maintained at 30°C and the detection wavelength was set at 230 nm for paeoniflorin, 254 nm for aloe-emodin, rhein, emodin, chrysophanol, and physcion, 280 nm for naringin, hesperidin, neohesperidin, and baicalin.
RESULTS: The developed method provided satisfactory precision and the accuracy of this method was in the range from 94.0% to 103.1%, all of the 10 compounds showed good linearity (r > 0.999) in a detected concentration range.
CONCLUSION: The validated method was successfully applied to the simultaneously of these active components in Dachaihu Granule from different production batches.

Entities:  

Keywords:  Dachaihu granule; high-performance liquid chromatographic-diode array detector; multi-components; multi-wavelength; quality control

Year:  2013        PMID: 23661991      PMCID: PMC3647391          DOI: 10.4103/0973-1296.108136

Source DB:  PubMed          Journal:  Pharmacogn Mag        ISSN: 0973-1296            Impact factor:   1.085


INTRODUCTION

Dachaihu Granule (DCHG) is derived from a well-known traditional Chinese formula named “Dachaihu decoction”, which was founded by ZhongJing Zhang, a famous medical scientist during the Eastern Han Dynasty of China. The formula is a combination of eight medicinal materials, including Bupleuri Radix, Scutellariae Radix, Rhei Radix et Rhizome, Aurantii Fructus Immaturus, Paeoniae Radix Alba, Pinelliae Rhizoma Praeparatum Cum Zingibere et Alumine, Zingiberis Rhizome Recens, and Jujubae Fructus. Recent study showed that DCHG had a significant effect on curing acute or chronic cholecystitis in clinical practice.[1-2] Pharmacological studies and clinical practice also have demonstrated that DCHG has many biological functions, such as antibacterial, antiulcer, preventing atherosclerosis, and protecting liver and gallbladder.[3-7] Moreover, it is also an effective adjunctive therapy for the cure of pediatric high fever, gastritis, and pancreatitis.[8-10] However, it is not yet clear what the bioactive constituents and mechanisms of DCHG are, although it is known that DCHG has numerous and diverse compounds, including flavone, saponin, terpene, coumarin, anthraquinones, etc. As we know, paeoniflorin (PA) has a well known effect on treating inflammation.[11] Aloe-emodin (AE), rhein (RH), emodin (EM), chrysophanol (CH), and physcion (PH), which were extracted from Rhei Radix et Rhizome, were proved to be effective components of antiinflammatory, protecting liver and gallbladder.[12-13] Flavone compounds including naringin (NA), hesperidin (HE), neohesperidin (NE), and baicalin (BA)[14-17] also have bioactivity, and their chemical structures are shown in Figure 1. Generally, NA, HE, and BA were believed to be the main active constituents and were chosen as marker compounds for the quality evaluation and standardization of DCHG. However, due to multiple compounds that might be associated with the therapeutic functions, a single or a few marker compounds could not be responsible for the overall pharmacological activities of DCHG. Therefore, it is urgently needed to establish a comprehensive quality evaluation method based on analysis of the whole bioactive compounds in order to accurately control the quality of this herbal drug.
Figure 1

The chemical structures of the investigated components: paeoniflorin (PA), aloe-emodin (AE), rhein (RH), emodin (EM), chrysophanol (CH), physcion (PH), naringin (NA), hesperidin (HE), neohesperidin (NE), and baicalin (BA)

The chemical structures of the investigated components: paeoniflorin (PA), aloe-emodin (AE), rhein (RH), emodin (EM), chrysophanol (CH), physcion (PH), naringin (NA), hesperidin (HE), neohesperidin (NE), and baicalin (BA) Previously, BA from DCHG was analyzed and three marker constituents (NA, HE, and BA) from Dachaihudecocetion were simultaneously analyzed with iso-gradient method for the quality control of the medicine.[18-19] Although HPLC methods have been applied to determine some of the constituents in crude drugs and Chinese patented medicine,[20-22] no analytical method has been reported for simultaneous determination of 10 major constituents in DCHG. Hence, it is very important to establish a method for quality control of these bioactive compounds, which could help to evaluate the quality of the herbal formula. In this study, the method of HPLC-DAD has been developed for the simultaneously qualitative and quantitative analysis of 10 bioactive compounds:PA, AE, RH, EM, CH, PH, NA, HE, NE, and BA.

MATERIALS AND METHODS

Chemical and reagents

Sample DCHG was supplied by Nantong Essence Pharmaceutical Co., Ltd. (Jiangsu, China). Standard substances including PA, AE, RH, EM, CH, PH, NA, and BA were purchased from the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). Standard substances including NA and NE were purchased from the Nanjing ZeLang Medicine Photochemistry Technology Co., Ltd. (Jiangsu, China), the purity of these reference compounds were determined to be more than 98% by HPLC analysis. The HPLC grade methanol and acetonitrile were purchased from Tedia (Fairfield, USA). Acetic acid (analytical reagents) was purchased from LingFeng Chemical Reagent Company (Shanghai, China). Other reagents were all of analytical grade. Ultra pure water was obtained in a Milli-Q system (Milford, MA, USA).

Instrument and chromatographic conditions

The HPLC system 1200 series (Agilent Technologies, USA) equipped with the Chem Station software (Agilent Technologies) and comprised of a double solvent delivery pump, an online vacuum degasser, an auto sampler, a thermostatic compartment and a diode array detector, were used for the chromatographic analysis. All separations were carried out on a Kromasil C18 column (250 × 4.6 mm i.d. with 5.0 μm particle size) from Hanbang Science and Technology (Jiangsu, China). Mobile phase A was 0.2% (v/v) acetic acid aqueous solution and phase B was acetonitrile. The elution was performed using a linear gradient of 5–19% B at 0–13 min, 19–26% B at 13–28 min, 26% B at 28–36 min, 26–40% B at 36–50 min, 40–85% B at 50–69 min, 85% B at 69–75 min. The flow rate was 1.0 mL/min and column temperature was maintained at 30°C, detect wavelength was set at 230 nm for PA, 254 nm for AE, RH, EM, CH, and PH, and 280 nm for NA, HE, NE, andBA. The injection volume was 10 μL. The peak identification was based on the retention time and the DAD spectrum against the standard presented in the chromatogram.

Standard solution preparation

The standard stock solutions of PA 0.1254, AE 0.0092, RH 0.0212, EM 0.0097, CH 0.0191, PH 0.0101, NA 0.1938, HE 0.1096, NE 0.1287, and BA 0.4525 mg/mL were prepared in methanol and stored away from light at 4°C. Working solutions of the low concentration were prepared by appropriate dilution of the stock solution.

Sample solution preparation

The powder of DCHG (about 1.0 g) was extracted with 25.00 mL methanol for 30 min in an ultrasonic bath for one time. Adding up the loss of weight by methanol after cooling, then, the solution was filtered through a syringe filter (0.45 μm) before being injected into the HPLC system for analysis.

RESULTS AND DISCUSSION

Chromatographic separation

In order to optimize the extraction conditions for achievement of quantitative extraction, variables involved in the procedure such as solvent, extraction method and extraction time were optimized. Pure and aqueous methanol or ethanol solutions also were tried as the extraction solvent, the best solvent was found to be pure methanol which gave rise to optimum extraction of all the 10 components. Compared with refluxing extraction, the ultrasonic treatment procedure was found to be the better extraction method for all the 10 components. In order to investigate extraction time, powdered DCHG samples were extracted with 25 mL pure methanol 20, 30, 45, and 60 min, respectively. The results suggested that all the 10 components were almost completely extracted by pure methanol at one time for 30 min. Due to the complex composition of the sample solution, different mobile phases (methanolwater, methanolwateracetic acid, acetonitrilewater, and acetonitrilewateracetic acid) were attempted to elute the investigated 10 components. In order to enhance resolution and eliminate tailing of the peaks of the target compounds, formic acid and acetic acid were added in the mobile phase. Considering the total resolution of the chromatographic separation, the running time and solvent consumption, the mobile phase acetonitrilewateracetic acid was chosen for the separation. The typical chromatographic profiles of the blank, standard solution, and the real sample solution were shown in Figure 2. On the basis of the absorption maxima of the 10 compounds in UV spectra acquired by use of the diode array detector, the monitoring wavelength was set at 230 nm for PA, 254 nm for AE, RH, EM, CH, and PH, and 280 nm for NA, HE, NE, and BA, respectively. The detections at three wavelengths were carried out to improve the sensitivity and selectivity for the quantitative analysis.
Figure 2

HPLC chromatograms of mixed reference substance and samples at different wavelength;(a) mixed reference substance and sample at 230 nm; (b) mixed reference substance and sample at 254 nm; (c) mixed reference substance and sample at 280 nm; the peak marked was 1-PA, 2-AE, 3-RH, 4-EM, 5-CH, 6-PH 7-NA, 8-HE, 9-NE, 10-BA

HPLC chromatograms of mixed reference substance and samples at different wavelength;(a) mixed reference substance and sample at 230 nm; (b) mixed reference substance and sample at 254 nm; (c) mixed reference substance and sample at 280 nm; the peak marked was 1-PA, 2-AE, 3-RH, 4-EM, 5-CH, 6-PH 7-NA, 8-HE, 9-NE, 10-BA

Linearity, range, and limits of detection

Integrated chromatographic peak areas (Y) were plotted against tpan class="Chemical">he corresponding concentrations (X μg/mL) of the 10 constituents in the standard solutions to obtain calibration curves based on linear regression analysis. The regression curves were obtained from six concentration levels and all of them had good linearity (r >0.999) in the investigated ranges [Table 1]. The working solutions of the analysis were further diluted with methanol to yield a series of appropriate concentrations. The limits of detection (LOD) and the limits of quantization (LOQ) for each investigated compounds can be seen in Table 1.
Table 1

Linear relationships between peak area and concentration

Linear relationships between peak area and concentration

Precision, repeatability, and stability

The injection of continuous six times using the same sample was employed for the injection precision, and the injection of six different samples, which were obtained through the same sample preparation procedure, was used for the analysis repeatability. Furthermore, the test of injection precision was determined by the standard solutions, and the test of analysis repeatability was investigated by the real sample solution. The instrument precision was examined by the performance of the intra-day and inter-day assays by six injections of the mixture standard solutions used above. The intra-assay precision was performed with the interval of 2 h in 1 day, and the inter-assay precision was performed over 3 days. The precision result of the solution is presented in Table 2, and it was shown that the RSD(relative standard deviation) values of retention time were lower than 0.25%, while the RSD values of peak area were lower than 2.5% both for the intra-assay and inter-assay precision. Results of injection repeatability of the solution are shown in Table 3, and the RSD values were lower than 3%. The same real sample was analyzed within 24 h at 30°C for the stability test, and the solution was found to be stable while RSD values of the retention time and peak area were both lower than 2.0%.
Table 2

Intra-assay and inter-assay precision of the method (n = 6)

Table 3

Repeatability of the method (n = 6)

Intra-assay and inter-assay precision of the method (n = 6) Repeatability of the method (n = 6)

Accuracy

Neither a standard method for tpan class="Chemical">he determination of these active components nor a standard reference had been established because of the complexity of Chinese medicines. So accuracy of the standard from samples is generally used to evaluate the accuracy of the newly developed analytical method. Three different quantities (low, medium, and high) of the authentic standards were added into the known real sample. The mixtures were extracted as sample preparation described above, and was analyzed using the developed HPLC method mentioned above. Then the quantity of each component was subsequently achieved from the corresponding calibration curves. The recovery of the investigated components ranged from 94.0% to 103.1%, and their RSD values were all less than 3.0% [Table 4]. It was known from the recovery tests that this developed method manifested the reliability and accuracy for the measurement of these components.
Table 4

Recovery of the 10 compounds (n = 3)

Recovery of the 10 compounds (n = 3)

Sample analysis

For the simultaneous determination of 10 major components in Chinese medicine DCHG from different production batches, the developed HPLC method was used by comparing the retention time with those of standards. The amounts of the 10 compounds in the samples were then calculated. The results shown in Table 5 indicate that the content of anthraquinones was lower than other components between batches. However, the content of some components such as NA, HE, NE, and BA were higher than other compounds. Therefore, the simultaneous determination of all the components contained in DCHG is necessary to improve the quality control of this drug.
Table 5

Content of 10 Compounds in Samples of Dachaihu granule

Content of 10 Compounds in Samples of Dachaihu granule

CONCLUSION

RP-HPLC with DAD was found to be effective for the simultaneous detection and determination of 10 major bioactive constituents (PA, AE, RH, EM, CH, PH, NA, HE, NE, and BA) in Chinese traditional medicine DCHG. This is also the first report of an accurate and reliable analytical method for the simultaneous determination. High linearity, repeatability, precision, accuracy and reliability were presented in the method validation procedure. The proposed method is promising to improve the quality control of DCHG.
  3 in total

1.  Simultaneous determination of 13 bioactive compounds in Herba Artemisiae Scopariae (Yin Chen) from different harvest seasons by HPLC-DAD.

Authors:  Xiao-jie Tan; Qing Li; Xiao-hui Chen; Zhi-wei Wang; Zheng-yuan Shi; Kai-shun Bi; Ying Jia
Journal:  J Pharm Biomed Anal       Date:  2008-04-15       Impact factor: 3.935

2.  Simultaneous qualitation and quantification of thirteen bioactive compounds in Flos lonicerae by high-performance liquid chromatography with diode array detector and mass spectrometry.

Authors:  Zheng-Ming Qian; Hui-Jun Li; Ping Li; Mei-Ting Ren; Dan Tang
Journal:  Chem Pharm Bull (Tokyo)       Date:  2007-07       Impact factor: 1.645

3.  Simultaneous determination of geniposide, chlorogenic acid, crocin1, and rutin in crude and processed Fructus Gardeniae extracts by high performance liquid chromatography.

Authors:  Enhong Ouyang; Chengrong Zhang; Xiaomeng Li
Journal:  Pharmacogn Mag       Date:  2011-10       Impact factor: 1.085

  3 in total
  5 in total

1.  Chromatographic fingerprinting analysis of Zhizhu Wan preparation by high-performance liquid chromatography coupled with photodiode array detector.

Authors:  Hui Sun; Xi Chen; Aihua Zhang; Tetsuro Sakurai; Jinzhong Jiang; Xijun Wang
Journal:  Pharmacogn Mag       Date:  2014-10       Impact factor: 1.085

2.  Chemical interaction between Paeonia lactiflora and Glycyrrhiza uralensis, the components of Jakyakgamcho-tang, using a validated high-performance liquid chromatography method: herbal combination and chemical interaction in a decoction.

Authors:  Jung-Hoon Kim; Hyeun-Kyoo Shin; Chang-Seob Seo
Journal:  J Sep Sci       Date:  2014-08-11       Impact factor: 3.645

3.  Development and validation of an high-performance liquid chromatography-diode array detector method for the simultaneous determination of six phenolic compounds in abnormal savda munziq decoction.

Authors:  Shuge Tian; Wenxian Liu; Feng Liu; Xuejia Zhang; Halmuart Upur
Journal:  Pharmacogn Mag       Date:  2015 Jan-Mar       Impact factor: 1.085

4.  Preliminary identification of the absorbed bioactive components and metabolites in rat plasma after oral administration of Shaoyao-Gancao decoction by ultra-performance liquid chromatography with electrospray ionization tandem mass spectrometry.

Authors:  Ping Wang; Quan-Wei Yin; Ai-Hua Zhang; Hui Sun; Xiu-Hong Wu; Xi-Jun Wang
Journal:  Pharmacogn Mag       Date:  2014-10       Impact factor: 1.085

5.  Targeted bile acid profiles reveal the liver injury amelioration of Da-Chai-Hu decoction against ANIT- and BDL-induced cholestasis.

Authors:  YueHua Zhou; YunZhong Zhou; YiFei Li; Wei Sun; ZhaoLong Wang; Long Chen; Ye He; XiaoLong Niu; Jialiang Chen; Guangtao Yao
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.